Inventor · disambiguated record
William L. Klein
Also filed as: KLEIN WILLIAM · KLEIN WILLIAM L
18 granted patents·19 pending applications·648 citations·filing 1985–2025
95Inventor score
Top patents by PatentIndex Score
37 records- 0194US4962133AMethod of making highly adsorptive copolymersDOW CORNING·Filed 1989·Granted Oct 9, 1990·87 cites·10 claims
- 0293US6218506B1Amyloid β protein (globular assembly and uses thereof)UNIV NORTHWESTERN·Filed 1997·Granted Apr 17, 2001·215 cites·8 claims
- 0392US7780963B2Anti-ADDL antibodies and uses thereofMERCK & CO INC·Filed 2005·Granted Aug 24, 2010·25 cites·14 claims
- 0492US4772462AHair products containing dimethyl diallyl ammonium chloride/acrylic acid-type polymersCALGON CORP·Filed 1986·Granted Sep 20, 1988·108 cites·8 claims
- 0589US7638283B2Amyloid β protein (globular assembly and uses thereof)UNIV NORTHWESTERN·Filed 2005·Granted Dec 29, 2009·11 cites·2 claims
- 0689US7461640B1Cooling system with boiling preventionHONEYWELL INT INC·Filed 2007·Granted Dec 9, 2008·20 cites·19 claims
- 0787US7811563B2Anti-addl antibodies and uses thereofUNIV NORTHWESTERN·Filed 2005·Granted Oct 12, 2010·9 cites·14 claims
- 0881US8383113B2Anti-ADDL antibodies and uses thereofUNIV NORTHWESTERN·Filed 2012·Granted Feb 26, 2013·4 cites·12 claims
- 0980US4764365APersonal skin care products containing dimethyl diallyl ammonium chloride/acrylic acid-type polymersCALGON CORP·Filed 1986·Granted Aug 16, 1988·52 cites·8 claims
- 1076US8889138B2Anti-ADDL antibodies and uses thereofACTON PAUL·Filed 2010·Granted Nov 18, 2014·3 cites·12 claims
- 1176US8128930B2Anti-ADDL antibodies and uses thereofACTON PAUL·Filed 2010·Granted Mar 6, 2012·3 cites·13 claims
- 1272US5208038ACoacervated highly absorptive polymersDOW CORNING·Filed 1989·Granted May 4, 1993·46 cites·13 claims
- 1369US2021386879A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 1468US5135660AMethod of recovering oil from the surface of waterDOW CORNING·Filed 1991·Granted Aug 4, 1992·32 cites·1 claims
- 1564US8507206B2Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)LAMBERT MARY P·Filed 2005·Granted Aug 13, 2013·4 cites·1 claims
- 1662US2014322731A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2014·Application pending·0 cites
- 1761US2017209604A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2017·Application pending·0 cites
- 1860US2024325319A1Inhibitors of amyloid beta oligomerization and therapeutic uses thereofUNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 1959US2024238355A1Compositions and methods for treating alzheimer's diseaseUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 2058US4675178AUse of cationic polymers (polydimethyldialkyl ammonium chloride-acrylamide copolymers and dimethyldialkyl ammonium chloride) to increase deposition and/or retention of active agent (S) of deodorant formulations on surfacesCALGON CORP·Filed 1985·Granted Jun 23, 1987·29 cites·5 claims
- 2158US2009285804A1Anti-ADDLs antibodies and uses thereofKLEIN WILLIAM L·Filed 2009·Application pending·0 cites
- 2257US2007213512A1Amyloid beta peptide analogs and assemblies thereofKRAFFT GRANT A·Filed 2007·Application pending·0 cites
- 2357US2016213794A1Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules and uses thereofUNIV NORTHWESTERN·Filed 2016·Application pending·0 cites
- 2456US2013150560A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 2556US2013236466A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 2656US2013078269A1Amyloid beta peptides, assemblies thereof, and related methodsUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 2755US2003068316A1Anti-ADDL antibodies and uses thereofFiled 2002·Application pending·0 cites
- 2854US2025262337A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2025·Application pending·0 cites
- 2954US2007048312A1Anti-ADDL antibodies and uses thereofKLEIN WILLIAM L·Filed 2006·Application pending·0 cites
- 3053US11541086B2Compositions and methods for treating Alzheimer's diseaseUNIV NORTHWESTERN·Filed 2020·Granted Jan 3, 2023·0 cites·10 claims
- 3153US9095629B2Magnetic nanostructures as theranostic agentsDRAVID VINAYAK P·Filed 2010·Granted Aug 4, 2015·0 cites·12 claims
- 3252US7964359B2Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearanceACUMEN PHARMACEUTICALS INC·Filed 2007·Granted Jun 21, 2011·0 cites·2 claims
- 3347US2008176252A1Amyloid beta-derived diffusible ligands (ADDLs), ADDL-surrogates, ADDL-binding molecules, and uses thereofKRAFFT GRANT A·Filed 2005·Application pending·0 cites
- 3446US2013330837A1Monoclonal antibodies that target pathological assemblies of amyloid beta (abeta)ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3545US2005059634A1Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer's and related diseasesFiled 2004·Application pending·0 cites
- 3637US2006178302A1Amyloid beta protein (globular assembly and uses thereof)NORTHWESTERN UNIVERSITY & THE·Filed 2005·Application pending·0 cites
- 3733US2008306074A1Compositions Comprising Addl Receptors, Related Compositions, and Related MethodsLACOR PASCALE N·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →